Archives for 

Interchangeability

IRELAND’S DEPARTMENT OF HEALTH IS REQUESTING COMMENTS REGARDING ITS NATIONAL BIOSIMILARS MEDICINES POLICY

Biosimilar News  •  Interchangeability  •  Legislation Tracker  •  Uncategorized
Ireland’s Department of Health (the “Department”) recently reported on its website that it is “developing a National Biosimilar Medicines Policy to promote the use of biosimilar medicines and to create a sustainable environment for […]

View More

Regulators Highlight Differing International Biosimilar Regulations; Interchangeability Guidance May Slip to 2017

Biosimilar News  •  BPCIA and Related U.S. Statutes  •  Interchangeability  •  Regulatory Guidances
Bloomberg BNA reported that a panel of regulators at the DIA 2016 Biosimilar Conference in Washington highlighted the differences among biosimilar regulations internationally and the ongoing changes as countries revise their biosimilar guidances. For […]

View More